Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Celiac Disease Treatment Companies

Celiac Disease Treatment companies are dedicated to addressing the unique needs of individuals with celiac disease. Specializing in research and development, they offer innovative treatments and products that support gluten-free lifestyles, improving the management and well-being of those affected by this autoimmune condition.

Celiac Disease Treatment Key Companies


Latest Celiac Disease Treatment Companies Update:

Chugai Pharmaceutical Published promising results from a non-clinical study on DONQ52, a medication targeting the immune response to gluten without affecting the whole immune system. A phase 1 clinical trial is ongoing.

Topas Therapeutics Their phase 2a clinical trial for TPM502, an antigen-specific nanoparticle therapy for celiac disease, is underway. This therapy aims to induce immune tolerance towards gluten.

Alnylam Pharmaceuticals Announced positive preliminary results from a phase 1b study of lumasiran for celiac disease. Lumasiran targets a specific gene involved in the immune response to gluten.

ImmusanT This clinical-stage biotech company is developing ITM-15, a potential first-in-class T-cell therapy for celiac disease. They announced the initiation of a phase 1b/2a clinical trial in December 2023.

List of Celiac Disease Treatment Key companies in the market

  • General Mills Inc.

  • Innovate Biopharmaceutical

  • ActoBio

  • Glenmark Pharmaceuticals Company Ltd.

  • Takeda Pharmaceuticals Company Ltd.

  • Zydus Pharmaceuticals Inc.

  • BioLineRx

  • West-Ward Pharmaceuticals Company Ltd.

  • Calypso Biotech SA

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.